Michael Inouye
Professor Michael Inouye from the University of Cambridge is a key figure in cancer research, particularly in the application of genetic assessments for disease risk. He views the recent findings on a saliva test for prostate cancer as a landmark development in the field, but acknowledges that significant work remains before such tests can be routinely implemented in clinical settings.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 8.00 | 0.03% | +0% | 67,886,011 | 17,799 | $2,700,000 | 708$ |
| Saudi Arabia | 1 | 8.00 | 0.05% | +0% | 34,813,871 | 18,880 | $700,000 | 380$ |
| Totals | 2 | 102,699,882 | 36,679 | $3,400,000 | 1,088$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Saudi Arabia:
Michael Inouye from the University of Cambridge believes the study is a landmark in using genetics to assess risks.
8
United Kingdom:
Prof Michael Inouye, from the University of Cambridge, believes the study will be seen as a landmark in using genetics to assess risk.
8